Teva Pharma's most recent trend suggests a bearish bias. One trading opportunity on Teva Pharma is a Bear Call Spread using a strike $60.00 short call and a strike $65.00 long call offers a potential 17.92% return on risk over the next 14 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $60.00 by expiration. The full premium credit of $0.76 would be kept by the premium seller. The risk of $4.24 would be incurred if the stock rose above the $65.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Teva Pharma is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Teva Pharma is bearish.
The RSI indicator is at 33.22 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Teva Pharma
Fri, 02 Oct 2015 04:39:07 GMT
Teva Pharma Makes a $2.3 Billion Acquisition
Thu, 01 Oct 2015 22:18:17 GMT
Massive, unexpected drug price increases are happening all the time
Thu, 01 Oct 2015 19:26:45 GMT
Teva making its second multibillion-dollar buy this year
Thu, 01 Oct 2015 18:00:09 GMT
Teva Pharm to buy Mexican drugmaker Rimsa for $2.3 bln
Thu, 01 Oct 2015 16:29:25 GMT
Also on Market Tamer…
Follow Us on Facebook